Session Details
[S11☆]Game Changer for Next-Generation Drug Discovery —Leveraging the Latest Research Information from AMED BINDS and Connecting It to Drug Discovery—
Fri. Mar 27, 2026 1:10 PM - 4:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 7:10 AM UTC
Fri. Mar 27, 2026 4:10 AM - 7:10 AM UTC
Room 05 (F401)
Organizer: Kazutake Tsujikawa (Grad. Sch. Pharm. Sci., UOsaka), Tatsuya Zenkoh (Grad. Sch. Phar. Sci., UTokyo)
オーガナイザー挨拶
辻川 和丈(阪大院薬)
AMED BINDSプログラムスーパーバイザー挨拶
井上 豪(阪大院薬)
[S11-1]New progress in academia drug discovery screening: Implementation of Affinity Selection-Mass Spectrometry (AS-MS) technology at Drug Discovery Initiative
○Riyo Imamura1 (1. UTokyo)
[S11-2]Cell-Free Protein Synthesis for Drug Discovery: From Tough-Target Production to Target Deconvolution
○Hiroyuki Takeda1 (1. PROS, Ehime Univ.)
[S11-3]Support for Metabolome and Proteome Analyses in the AMED BIND Project
○Takeshi Bamba1 (1. MIB, Kyushu Univ.)
[S11-4]Development and applications of highly functional intestinal monolayers derived from human iPS cells using organoid technology
○Tatsuya Inui1,2, Hiroyuki Mizuguchi1,2,3,4,5 (1. Grad. Sch. Pharm. Sci., UOsaka, 2. NIBN, 3. MEI cent., UOsaka, 4. OTRI, UOsaka, 5. CiDER, UOsaka)
[S11-5]BSL3 cryo-electron microscopy for drug discovery of infectious diseases
○Hideo Fukuhara1, Katsumi Maenaka1,2,3 (1. Hokkaido U, 2. Hokkaido U, 3. Kyushu U)
[S11-6]CrypToth: A Computational Approach to Discover Hidden Ligand-Binding Pockets for Novel Drug Target Discovery
○Jun Koseki1 (1. AIST CMB)
[S11-7]Advancement of Organic Synthesis for Diverse Modalities and Its Contribution to Life Science and Drug Discovery
○Satoshi Yokoshima1 (1. Grad Sch Pharm Sci, Nagoya Univ)
